enVVeno Competitors and Similar CompaniesClear all
Kymab's competitors and similar companies include Histocell and Neofluidics.
 Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. | ||
Founding Date | Founding Date 2009 | Founding Date 2011 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ | Locations Derio, ES HQ Larrabetzu, ES | Locations San Diego, US HQ Lubbock, US |
Employees | Employees 407% decrease | Employees 365% decrease | Employees 3 |
Funding | |||
Latest funding round | Latest funding round $ 100m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 175k (over 8 years ago) |
Total funding raised | Total funding raised $ 220.4m | Total funding raised N/A | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Histocell
HQ
Derio, ES
Employees
36↓ 5% decrease
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View company
Neofluidics
HQ
San Diego, US
Employees
3
Neofluidics is a company that develops tools and technology for enhanced microfluidics.
View company